OBJECTIVE Low anterior resection syndrome (LARS) is a term for functional bowel complaints occurring after low anterior resection. Symptoms can range from faecal incontinence and frequent loose stools to urgency and incomplete emptying with great impact on quality of life. Little is known about the longitudinal evolution of LARS and the impact of different schedules of neoadjuvant chemoradiotherapy combined with surgery. The investigators aim to investigate the incidence and evolution of functional bowel complaints in function of different neoadjuvant treatment regimens, type of surgery and adjuvant therapy in patients who undergo surgery for rectal cancer. The investigators focus on following objectives: evolution of LARS- and COREFO-scores per treatment regimen and their impact on work incapacity; identification of possible risk factors potentially related to functional outcome; monitoring and treatment of LARS. METHODS This will be a multicentre prospective interventional study. The study population will consist of adult patients with rectal cancer, regardless of any neo-adjuvant therapy. Patients will be included for 5 years with a 2 year postoperative follow-up. Interim analysis will be made after 2 years of inclusion. Patients with intellectual disability or clinical colon obstruction are excluded. Automated online questionnaires including LARS and COREFO scores, incapacity for work and defecation quality will be sent at different time points (figure 1) using REDCap. RESULTS and CONCLUSIONS Longitudinal change of LARS- and COREFO-scores will be visually summarized. Patient, disease or procedure specific risk factors will be assessed as well. LARS is proven to be the principal postoperative problem after rectal surgery. If the investigators can predict the severity of LARS (minor or major LARS), this can be extremely helpful in deciding whether to perform a sphincter-sparing resection or a rectal amputation instead. Furthermore, the investigators want to offer perspective to patients who are susceptible to a disturbed postoperative bowel function.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
100
Online questionnaire regarding LARS- and COREFO-scores, quality of defecation process, incapacity for work and initiation of treatment for potential LARS at different moments in time
University Hospital Antwerp
Edegem, Antwerp, Belgium
RECRUITINGThe evolution of the COREFO-score (Colorectal Functional Outcome questionnaire) at 2 years after rectal surgery compared to baseline (absolute difference) will be examined
27 questions on 5-point Likert scale Higher score = worse bowel function
Time frame: 2 years from when rectal resection or stoma reversal was performed
Evolution of LARS-score (low anterior resection syndrome) at 2 years after rectal surgery compared to baseline (absolute difference)
0-20 = no LARS 21-29 = minor LARS 30-42 = major LARS
Time frame: 2 years from when rectal resection or stoma reversal was performed
The evolution of the LARS-score (low anterior resection syndrome) at 2 years after rectal surgery compared to baseline (relative difference) will be examined.
0-20 = no LARS 21-29 = minor LARS 30-42 = major LARS
Time frame: 2 years from when rectal resection or stoma reversal was performed
The evolution of the COREFO-score (Colorectal Functional Outcome questionnaire) at 2 years after rectal surgery compared to baseline (relative difference) will be examined
27 questions on 5-point Likert scale Higher score = worse bowel function (min 0 - max 100)
Time frame: 2 years from when rectal resection or stoma reversal was performed
The evolution of the LARS-score (low anterior resection syndrome) in the absence of baseline data will be examined as well (absolute difference), comparing 2-year outcome to earliest results.
0-20 no LARS 21-29 minor LARS 30-42 major LARS (min 0 - max 42)
Time frame: 2 years from when rectal resection or stoma reversal was performed
The evolution of the LARS-score (low anterior resection syndrome) in the absence of baseline data will be examined as well (relative difference), comparing 2-year outcome to earliest results.
0-20 no LARS 21-29 minor LARS 30-42 major LARS (min 0 - max 42)
Time frame: 2 years from when rectal resection or stoma reversal was performed
The evolution of the COREFO-score (Colorectal Functional Outcome questionnaire) in the absence of baseline data will be examined as well (absolute difference), comparing 2-year outcome to earliest results.
27 questions on 5-point Likert scale Higher score = worse bowel function (min 0 - max 100)
Time frame: 2 years from when rectal resection or stoma reversal was performed
The evolution of the COREFO-score (Colorectal Functional Outcome questionnaire) in the absence of baseline data will be examined as well (relative difference), comparing 2-year outcome to earliest results.
27 questions on 5-point Likert scale Higher score = worse bowel function (min 0 - max 100)
Time frame: 2 years from when rectal resection or stoma reversal was performed
LARS-score (low anterior resection syndrome) score at diagnosis
0-20 no LARS 21-29 minor LARS 30-42 major LARS (min 0 - max 42) LARS = low anterior resection syndrome Using a questionnaire Unit = mean score (0-42)
Time frame: At diagnosis = baseline
COREFO-score at diagnosis (Colorectal Functional Outcome questionnaire)
27 questions on 5-point Likert scale Higher score = worse bowel function (min 0 - max 100) COREFO = Colorectal Functional Outcome questionnaire Using a questionnaire Unit = mean score (0-100)
Time frame: At diagnosis = baseline
LARS-score (low anterior resection syndrome) after neo-adjuvant therapy
0-20 no LARS 21-29 minor LARS 30-42 major LARS (min 0 - max 42) LARS = low anterior resection syndrome Using a questionnaire Unit = mean score (0-42)
Time frame: After neo-adjuvant therapy (up to 6 months from baseline)
COREFO-score after neo-adjuvant therapy (Colorectal Functional Outcome questionnaire)
27 questions on 5-point Likert scale Higher score = worse bowel function (min 0 - max 100) COREFO = Colorectal Functional Outcome questionnaire Using a questionnaire Unit = mean score (0-100)
Time frame: After neo-adjuvant therapy (up to 6 months from baseline)
LARS-score (low anterior resection syndrome) shortly prior to surgery when there is a delay of 4 or more weeks after finishing neoadjuvant therapy
0-20 no LARS 21-29 minor LARS 30-42 major LARS (min 0 - max 42) LARS = low anterior resection syndrome Using a questionnaire Unit = mean score (0-42)
Time frame: 2 days prior to surgery
COREFO-score (Colorectal Functional Outcome questionnaire) shortly prior to surgery when there is a delay of 4 or more weeks after finishing neoadjuvant therapy
27 questions on 5-point Likert scale Higher score = worse bowel function (min 0 - max 100) COREFO = Colorectal Functional Outcome questionnaire Using a questionnaire Unit = mean score (0-100)
Time frame: 2 days prior to surgery
LARS-scores (low anterior resection syndrome) postoperatively after 1 month, 3 months, 6 months, 1 year and 2 years
0-20 no LARS 21-29 minor LARS 30-42 major LARS (min 0 - max 42) LARS = low anterior resection syndrome Using a questionnaire Unit = mean score (0-42)
Time frame: Postoperatively after 1 month, 3 months, 6 months, 1 year and 2 years
COREFO-scores (Colorectal Functional Outcome questionnaire) postoperatively after 1 month, 3 months, 6 months, 1 year and 2 years
27 questions on 5-point Likert scale Higher score = worse bowel function (min 0 - max 100) COREFO = Colorectal Functional Outcome questionnaire Using a questionnaire Unit = mean score (0-100)
Time frame: Postoperatively after 1 month, 3 months, 6 months, 1 year and 2 years
Evolution of quality of defecation process
Visual analogue scale 0-10 0 = worst defecation ever 10 = best defecation ever
Time frame: 2 years after rectal resection or stoma reversal
Incapacity for work
Time (days) between date of start work incapacity and date back to work (if not yet retired)
Time frame: At diagnose (baseline), 2 days after radiotherapy, 1 week after chemotherapy and 1 month after rectal resection
Initiation of treatment for potential LARS (low anterior resection syndrome) during follow-up
Yes/no: * Dietary measures * Medication (probiotics, antidiarrheals, ...) * Pelvic floor physiotherapy * Transanal irrigation, rectal irrigation, enema * Neuromodulation (neurostimulator) * Other Calculating proportion of patients who received treatment for LARS
Time frame: Up to 2 years after rectal resection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.